By Kathy McCormack

Intense Canadian wildfires are blanketing the northeastern U.S. in a dystopian haze, turning the air acrid, the sky yellowish gray and prompting warnings for vulnerable populations to stay inside.

The effects of hundreds of wildfires burning across the western provinces to Quebec could be felt as far away as New York City and New England, blotting out skylines and irritating throats.

U.S. authorities issued air quality alerts. Hazy conditions and smoke from the wildfires were reported across the Great Lakes region from Cleveland to Buffalo.

A smoky haze that hung over New York City much of the day Tuesday thickened in the late afternoon, obscuring views of New Jersey across the Hudson River and making the setting sun look like a reddish orb. In the Philadelphia area, dusk brought more of a lavender haze.

Sal and Lilly Murphy, of Brooklyn, likened the burning scent to a campfire. They said they could even smell the smoke indoors, in a Manhattan restaurant, then walked outside and saw a sky that looked like it was about to storm — but was rainless. Lilly wore a mask for protection.

“It’s a little scary,” Sal Murphy said.

Smoke from the fires has wafted through northeastern U.S. states for weeks now, but it’s only recently been noticeable in most places.

New York Gov. Kathy Hochul said Tuesday's hazy skies “were hard to miss,” and New York City Mayor Eric Adams encouraged residents to limit outdoor activities ”to the absolute necessities.”

Here's a closer look at what's happening and some suggested precautions for dealing with the haze:

WHAT'S HAPPENING?

Smoke from Canada's wildfires has been moving into the United States since last month. The most recent fires near Quebec have been burning for at least several days.

The EPA said hazy skies, reduced visibility and the odor of burning wood are likely, and that the smoke will linger for a few days in New England.

“It's not unusual for us to get fire smoke in our area. It's very typical in terms of northwest Canada,” said Darren Austin, a meteorologist and senior air quality specialist with the Rhode Island Department of Environmental Management. But the smoke usually has been aloft and doesn't affect people's health, he said.

The Quebec-area fires are big and relatively close, about 500 to 600 miles (roughly 800 to 970 kilometers) away from Rhode Island. And they followed wildfires in Nova Scotia, which resulted in a short-lived air quality alert on May 30, Austin said.

WHAT'S THE BIGGEST CONCERN?

Air quality alerts are triggered by a number of factors, including the detection of fine-particle pollution — known as “PM 2.5” — which can irritate the lungs.

“We have defenses in our upper airway to trap larger particles and prevent them from getting down into the lungs. These are sort of the right size to get past those defenses,” said Dr. David Hill, a pulmonologist in Waterbury, Connecticut, and a member of the American Lung Association's National Board of Directors. “When those particles get down into the respiratory space, they cause the body to have an inflammatory reaction to them.”

Trent Ford, the state climatologist in Illinois, said the atmospheric conditions in the upper Midwest creating dry, warm weather made it possible for small particulates to travel hundreds of miles from the Canadian wildfires and linger for days.

“It’s a good example of how complex the climate system is but also how connected it is,” Ford said.

WHO SHOULD BE CAREFUL?

Exposure to elevated fine particle pollution levels can affect the lungs and heart.

The air quality alerts caution “sensitive groups,” a big category that includes children, older adults, and people with lung diseases, such as asthma and chronic obstructive pulmonary disease.

Kids, who often are encouraged to go out and play, “are more susceptible to smoke for a number of reasons,” said Laura Kate Bender, the lung association's National Assistant Vice President, healthy air. “Their lungs are still developing, they breathe in more air per unit of body weight.”

WHAT CAN YOU DO FOR NOW?

It's a good time to put off that yard work and outdoor exercise. If you go out, consider wearing an N95 mask to reduce your exposure to pollutants.

Stay inside, keeping your doors, windows and fireplaces shut. It's recommended that you run the air conditioning on a recirculation setting.

“If you have filters on your home HVAC system, you should make sure they’re up to date and high quality,” Hill said. “Some people, particularly those with underlying lung disease, or heart disease, should consider investing in in air purifiers for their homes.”

Associated Press reporter Katie Foody in Chicago contributed to this story.

This story has been updated with news from New York City.

Share:
More In Science
How Universities Might Be Playing for Time With Remote Learning as Omicron Surges
Universities like UCLA, Yale, and Duke have announced they're implementing remote learning amid the COVID omicron variant surge, despite President Biden recommending that K-12 schools should continue in-person education. Jared C. Bass, senior director for Higher Education at American Progress, joined Cheddar to break down what institutions of higher education might be considering differently. "I think some universities are allowing periods of a bit of a respite to allow students to get testing and make sure when they do return back to campus that they're healthy," he noted.
EV Expert Makes the Case for Domestic Mining for Lithium for Batteries
Supply chain issues have become one of the biggest roadblocks for the U.S. EV market, with production woes likely to stunt the industry's growth in 2022. Rich Steinberg, electric vehicle expert and industry advisor, told Cheddar that the Biden administration investing in domestic mining for essential minerals used in battery manufacturing — such as lithium — could help alleviate the bottlenecks. "Some of those same materials are available domestically, they just haven't been prioritized," he said, noting the paradox between green tech and "dirty" mining. "The good news is that there are ways to extract those materials cleanly."
Maker of First FDA-Approved Portable MRI Machine Hyperfine Goes Public
Hyperfine, the pioneer of the very first FDA-approved portable MRI device, made its public debut on the Nasdaq via a SPAC merger. CEO Dave Scott joined Cheddar's "Opening Bell" to discuss the IPO launch, the company's valuation at $580 million, and the impact of its machine called Swoop. "We can roll an MRI system, our MRI Swoop system, right into the room where you are, right up to your patient bedside, and scan you right there and get an image in less than an hour," he explained.
FDA Authorizes Pfizer's Covid-19 Treatment Pill Marking Pandemic Milestone
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home. Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Markets Continue to Feel Omicron Pressures
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
An Omicron Christmas, Student Loans & Love, Hate, Ate
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer COVID Treatment Pill Gets FDA Authorization
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
Semiconductor Industry Warns Shortage Could Last Deep Into 2022
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Load More